Get Fresh Tips Every Week!
Don't Miss Any Nurse Tips. Subscribe to the Nurse Tip Newsletter.

View Archive

Bookmark      RSS
 

Business Solutions
Our tips are powerful.
Our writers are experts.
Our results are guaranteed.

 

Listen to our Radio Show
Hot topics for both consumers
and webmarketers
on WebmasterRadio.FM

Every Wednesday, 4PM Eastern.

 

January 18, 2008, Newsletter Issue #268: Hormone Replacement Therapy Trial Halted Due to Cancer, Heart Risk


1

Tip of the Week

Researchers announced July 9, 2002 that they have halted one of the largest and best-designed studies of hormone replacement therapy because women taking the hormones after menopause had a greater risk of breast cancer, heart attack, stroke and blood clots than those who did not take the drugs.

More than 6 million women in the US currently take estrogen/progestin hormone combination therapy for a variety of reasons, including cures of hot flashes and other menopausal symptoms. The hope--and the hype--has been that such hormones would also confer a number of other advantages, including a reduced risk of heart disease. The study suggests that when women take the drugs for more than about 5 years, the risks of the hormones clearly outweigh the benefits.



2

About LifeTips

Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.



Learn more about our Exclusive Program we offer our clients.


 
LifeTips is part of ideaLaunch, the hub for a group of websites offering
solutions that help clients improve mind share, market share and profit online.
Privacy Guaranteed.
Satisfaction Required.